Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Protox Therapeutics Inc T.PRX

Bullboard (TSX:PRX)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by rijohn22on Jan 14, 2010 9:41am

P = 0.024 !!!

A little maddening when analysts use incorrect numbers. This Pvalue 0.024 indicates significant results by ANOVA analysis(analysis of variance). These results are great. Unfortunately placebo drop out ...more  
685
Post by sandufon Jan 14, 2010 12:11am

Missing the Point??

I normally invest only in ETFs for my foray into the stock market due to my lack of knowledge and limited ability to accept a large financial loss. When I became involved in the current  ...more  
638
Comment by risky_venturaon Jan 13, 2010 5:28pm

RE: RE: Analyst Schmanalyst

When I saw the recent PRX press release I sold all my PRX shares.  Since then, I've received some private information that has me considering buying back in at a lower price.  I don' ...more  
355
Discussion
Comment by bioboy10on Jan 13, 2010 9:00am

RE: Analyst Schmanalyst

Analyst Schmanalyst - So what your saying is that Rapoflo should not be on the market ??More from the schmanalyst with a Phd PRX302 meets IPSS standard that FDA accepted for otherexperimental BPH ...more  
392
Discussion
Post by risky_venturaon Jan 13, 2010 12:58am

Analyst Schmanalyst

A 3.3 difference between the control and experimental arms of the IIb is a disaster...the fact that it reached statistical significance (p<.05) means something, but not a great deal.A six-point ...more  
505
Comment by cabbieJBJon Jan 12, 2010 9:43pm

RE: RE: RE: re: re:Analyst report

Don't think you're missing anything.  If the board is reflective of the retail investor, they expected a 11 or 12 point improvement, not 9.3.  So the stock went down, despite the ...more  
311
Discussion
Comment by bioboy10on Jan 12, 2010 4:25pm

RE: RE: re: re:Analyst report

From what i understand in the research report, the price model includes milestone payments totalling $150 million, these are comparable numbers to the centrorelix partnership between Sanofi-Aventis ...more  
281
Discussion
Post by bioboy10on Jan 12, 2010 12:01am

re: re:Analyst report

This is what my broker sent over, best I can do cabbie. I dont have the other one. Versant PROTOX THERAPEUTICSPositive Phase II TRIUMPH data enhance partnership potential for lead drug ...more  
382
Comment by cabbieJBJon Jan 11, 2010 9:15pm

RE: Analyst recommendation

Bioboy - do you have copies or a link to the recos?  Much appreciated.  Thx, in advance. jb
272
Discussion
Post by bioboy10on Jan 11, 2010 7:19pm

Analyst recommendation

New recommendation from analysts following;versant - 12 month target  $1.75LOM     - 12 month target   $1.50Next critical date - 6 month followup and to see a upward ...more  
342
Post by major3on Jan 11, 2010 2:22pm

The results are very good and just what they expec

There are sone very important things to focus on in the press release.1)"A subgroup analysis was performed for subjects with severe BPH (baseline IPSS (greater than) 22, n equals 40). Results of ...more  
505
Comment by daytrader75on Jan 11, 2010 12:21pm

RE: Results

A 3.3 point improvement is a very positive result. I just don't understand what the stock price is doing......? 
382
Discussion
Post by bioboy10on Jan 11, 2010 12:13pm

Results

It is interesting, read the release and listened to the conference call. I think people were expecting a 5-6 point improvement in score not a 3.3 improvement.However Fahar seemed very excited about ...more  
350
Post by cabbieJBJon Jan 11, 2010 10:04am

What Gives

Up to $1.08...now at .81.  The results were positive, as was the cc.
391
Comment by risky_venturaon Jan 10, 2010 11:36pm

RE: The competition

The NYMX drug seems to be a viable competitor for PRX's BPH drug; in fact, it's novel drug appears to be a clone for PRX's.I went to the site where the NX-1207 paper was supposed to be ...more  
271
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities